About Invictus Oncology
Invictus Oncology is a company based in Delhi (India) founded in 2011 by Raghunath Mashelkar. Invictus Oncology has raised $6.99 million across 7 funding rounds from investors including Aarin Capital, Navam Capital and Sabre Partners India. Invictus Oncology operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Delhi, India
- Founders Raghunath Mashelkar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invictus Oncology Private Limited
- Date of Incorporation 11 Apr, 2011
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$115.53 K (USD)1534.01as on Mar 31, 2022
-
Net Profit
-$113.5 K (USD)13.7as on Mar 31, 2022
-
EBITDA
-$56.14 K (USD)43.76as on Mar 31, 2022
-
Total Equity Funding
$6.99 M (USD)
in 7 rounds
-
Latest Funding Round
$552.86 K (USD), Series A
Oct 22, 2016
-
Investors
Aarin Capital
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Invictus Oncology
Invictus Oncology has successfully raised a total of $6.99M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $552.86 thousand completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Invictus Oncology
Invictus Oncology has secured backing from 9 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Aarin Capital, Navam Capital and Sabre Partners India.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in engineering-driven deep-tech and science ventures in India.
|
Locked | Locked | Locked | |
|
Venture funding in technology-intensive businesses within healthcare, education, and India-centric markets.
|
Locked | Locked | Locked | |
|
Private equity investments in financial services, fintech, healthcare, and healthtech sectors in India.
|
Locked | Locked | Locked |
Investor details for Invictus Oncology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invictus Oncology
Investment portfolio details for Invictus Oncology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Invictus Oncology
Detailed financials for Invictus Oncology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invictus Oncology Comparisons
Peer comparison for Invictus Oncology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invictus Oncology
Invictus Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
|
| Locked | Locked | Locked |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
Detailed competitors of Invictus Oncology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invictus Oncology
Complete news archive for Invictus Oncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invictus Oncology
Invictus Oncology was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Invictus Oncology is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Invictus Oncology is a funded company, having raised a total of $6.99M across 7 funding rounds to date.
Annual revenue of Invictus Oncology is $115.53K as on Mar 31, 2022.
Invictus Oncology was founded in 2011 in Delhi, India, within the biotechnology sector focused on oncology. Antibody-drug conjugates and platinum-based chemotherapeutics are engineered using structure-activity relationships for targeted delivery to tumors. The product pipeline addresses lung, testicular, colorectal, and childhood cancers, with operations centered on developing treatments for tumor-specific applications.
Invictus Oncology's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Invictus Oncology has 9 investors. Key investors include Aarin Capital, Navam Capital, Sabre Partners India, Department of Biotechnology, and Sharad Lunia.
The valuation of Invictus Oncology is $16.54M as of Oct 2016.